The print font used should be of a size and type easily readable by the consumer. 4 Pharmaceutical Society of Australia (1999) Dose Administration Aid Guidelines. 4 Pharmaceutical Society of Australia (1999) Dose Administration Aid Guidelines. It is reasonable to perform some dose rounding in the final dose calculations in order to achieve simplicity of drug administration. This practice should be restricted to ‘special circumstances’ and should comply with relevant Australian, state or territory legislation, as some states restrict the re-filling of DAAs by registered nurses, as well as being in accordance with organisational policy. medicines administered on an ‘as required’ basis The care worker might remove medicines from a DAA or prompt a consumer to remove and take the medicine. The DAA should be clearly labelled with: Version 2. previous pagenext page, The following should not be placed in a DAA with other medicines: A registered nurse packing a DAA should document this activity in the consumer’s clinical record or notes. Copyright © 2020 Haymarket Media, Inc. All Rights Reserved directions for the use of each medicine medicines that might be affected when the backing of a DAA is heat-sealed, for example, soft gel caps. Before packing a DAA, the nurse should liaise with the doctor and dispensing pharmacist to obtain all relevant information. In some states and territories, a health care professional other than a pharmacist, that is, a registered nurse or Aboriginal Health Worker or Torres Strait Islander Health Worker, might fill a DAA. The guidelines include The following should not be placed in a DAA with other medicines: previous pagenext page, A registered nurse packing a DAA should document this activity in the consumer’s clinical record or notes. July 1999. www.psa.org.au Carers, families, care workers, community pharmacists, community nurses, doctors and other health care professionals all share a role in identifying any concerns about a consumer’s ability to manage their medicine. 2008;100:1511-1518). Even when medicine is supplied in a DAA, CMI should be provided, in accordance with professional guidelines. Where medicines are ordered for a defined short-course treatment, or in a complicated regimen, or where there are specific requirements regarding timing of administration in relation to meals and other medicines, such medicines should be in their original container or unit dose packs. solid dose cytotoxic preparations It is preferred that a registered nurse administer medicine from the container in which the medicine was originally dispensed, however, if a consumer has been supplied with a DAA (which has not been packed by a registered nurse), a registered nurse should only administer these medicines if they have a prescriber’s order and the medicines can be clearly identified from labels that state the name, colour, shape and details of manufacturers’ marks. If the pharmacist is not packing the DAA, information about medicines that might be unstable in a packaging system should be sought from a pharmacist, medicine information service or product information before the system is packed. The following should not be placed in a DAA with other medicines: The print font used should be of a size and type easily readable by the consumer. In the event of a dosage or medicine change where the consumer is self administering medicine from a DAA, the DAA should be returned immediately to the pharmacy or Aboriginal Medical Service for re-packing and re-delivery. All or part of a consumer’s medication regimen might be provided in a DAA. If the pharmacist is not packing the DAA, information about medicines that might be unstable in a packaging system should be sought from a pharmacist, medicine information service or product information before the system is packed. A registered nurse packing a DAA should document this activity in the consumer’s clinical record or notes. The Pharmaceutical Society of Australia (PSA) is the peak national professional pharmacy organisation, representing Australia's 32,000 pharmacists in all sectors and across all locations, working in or towards a career in pharmacy. medicines that might be affected when the backing of a DAA is heat-sealed, for example, soft gel caps. The following should not be placed in a DAA with other medicines: Role of care workers A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Published in the February 2000 issue of Oncology, the report is called a best-practice policy because of the lack of adequate data to formulate evidence-based guidelines … Safety and quality The cost of a DAA might also make it an unsuitable aid for some consumers. any specific instructions about the use of the medicine, including cautionary and advisory labels, including KEEP OUT OF REACH OF CHILDREN, and information about alteration of the dosage form where appropriate (refer to Guiding Principle 5 – Medication lists) Also addressed is advice on dealing with the supply of medicines to be issued periodically. It is preferred that a registered nurse administer medicine from the container in which the medicine was originally dispensed, however, if a consumer has been supplied with a DAA (which has not been packed by a registered nurse), a registered nurse should only administer these medicines if they have a prescriber’s order and the medicines can be clearly identified from labels that state the name, colour, shape and details of manufacturers’ marks. The DAA should be returned to the pharmacist for repackaging if there are any changes to the consumer’s medicines. Assessment A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Quality assurance The pharmacist should verify a medication order with the prescriber where necessary. The pharmacist should check for potential interactions and other considerations and with the consumer’s consent, inform the prescriber. July 1999. www.psa.org.au Provisions for registered nurses Care workers should monitor medication management by consumers and be guided by their organisations’ medication management policies and procedures if there are any suspected adverse medicine events. an indication in a prominent position that other medicines are contained in another DAA pack/s and are to be administered (e.g. directions for the use of each medicine any specific instructions about the use of the medicine, including cautionary and advisory labels, including KEEP OUT OF REACH OF CHILDREN, and information about alteration of the dosage form where appropriate (refer to Guiding Principle 5 – Medication lists) In the event of a dosage or medicine change where the consumer is self administering medicine from a DAA, the DAA should be returned immediately to the pharmacy or Aboriginal Medical Service for re-packing and re-delivery. Version 2. A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Top of page The DAA should be clearly labelled with: The pharmacist should verify a medication order with the prescriber where necessary. date of filling A carer or another nurse cannot administer medicines contained in a DAA that has been packed by a registered nurse. Administration From the January 05, 2009 Issue of Clinical Advisor, Already have an account? A registered nurse cannot administer medicines that are not clearly identifiable. It is preferred that a registered nurse administer medicine from the container in which the medicine was originally dispensed, however, if a consumer has been supplied with a DAA (which has not been packed by a registered nurse), a registered nurse should only administer these medicines if they have a prescriber’s order and the medicines can be clearly identified from labels that state the name, colour, shape and details of manufacturers’ marks. Even when medicine is supplied in a DAA, CMI should be provided, in accordance with professional guidelines. The print font used should be of a size and type easily readable by the consumer. Preparation Version 2. Aboriginal and Torres Strait Islander Health, Guiding principles for medication management in the community - July 2006. A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Provisions for registered nurses Top of page directions for the use of each medicine Before packing a DAA, the nurse should liaise with the doctor and dispensing pharmacist to obtain all relevant information. Labelling should include both the brand and the active ingredient names, reference to the colour, shape and size of the medicines, as well as manufacturer's marks that have been made on each product. 5 Pharmaceutical Society of Australia (2002) Dose Administration Aid Standards. All efforts should be made to have a DAA packed by a pharmacist. A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Preparation Quality assurance any other details as required by relevant Australian, state and territory legislation The DAA should be clearly labelled with: Quality assurance activities should be implemented to make sure packing processes are audited regularly. A registered nurse should only pack or re-pack a DAA if a pharmacist is unable to do so, if a consumer will self-administer medicines, and if the consumer’s health and welfare is at risk if the registered nurse does not do so. All or part of a consumer’s medication regimen might be provided in a DAA. All or part of a consumer’s medication regimen might be provided in a DAA. The care worker might remove medicines from a DAA or prompt a consumer to remove and take the medicine. Care workers should monitor medication management by consumers and be guided by their organisations’ medication management policies and procedures if there are any suspected adverse medicine events. Before packing a DAA, the nurse should liaise with the doctor and dispensing pharmacist to obtain all relevant information. A registered nurse should only pack or re-pack a DAA if a pharmacist is unable to do so, if a consumer will self-administer medicines, and if the consumer’s health and welfare is at risk if the registered nurse does not do so. A consumer might want to have complementary health care products and non-prescription medicines included in the DAA. solid dose cytotoxic preparations The registered nurse, care worker or community care provider should liaise with the consumer about returning the DAA to the pharmacy and arrange alternate supply where necessary. Even when medicine is supplied in a DAA, CMI should be provided, in accordance with professional guidelines. It is preferred that a registered nurse administer medicine from the container in which the medicine was originally dispensed, however, if a consumer has been supplied with a DAA (which has not been packed by a registered nurse), a registered nurse should only administer these medicines if they have a prescriber’s order and the medicines can be clearly identified from labels that state the name, colour, shape and details of manufacturers’ marks. Only solid oral medicines can be packaged in a DAA. Quality assurance 5 Pharmaceutical Society of Australia (2002) Dose Administration Aid Standards. Labelling of the DAA by the registered nurse should also be in accordance with organisational policy. Where medicines are ordered for a defined short-course treatment, or in a complicated regimen, or where there are specific requirements regarding timing of administration in relation to meals and other medicines, such medicines should be in their original container or unit dose packs. Provisions for registered nurses Top of page The care worker might remove medicines from a DAA or prompt a consumer to remove and take the medicine. July 1999. www.psa.org.au Role of care workers A carer or another nurse cannot administer medicines contained in a DAA that has been packed by a registered nurse. If a care worker is to help a consumer use their DAA and it is evident that the DAA has been tampered with, it should be returned to the pharmacist for repacking. Even when medicine is supplied in a DAA, CMI should be provided, in accordance with professional guidelines. Version 2. The print font used should be of a size and type easily readable by the consumer. the name, strength and form of all medicines supplied in the DAA, to enable identification of individual medicines This form uses a CAPTCHA to ensure that it is submitted by a person, instead of a machine or automated software. Quality assurance activities should be implemented to make sure packing processes are audited regularly. an indication in a prominent position that other medicines are contained in another DAA pack/s and are to be administered (e.g. date of filling In the event of a dosage or medicine change where the consumer is self administering medicine from a DAA, the DAA should be returned immediately to the pharmacy or Aboriginal Medical Service for re-packing and re-delivery. All efforts should be made to have a DAA packed by a pharmacist. any specific instructions about the use of the medicine, including cautionary and advisory labels, including KEEP OUT OF REACH OF CHILDREN, and information about alteration of the dosage form where appropriate (refer to Guiding Principle 5 – Medication lists) The DAA should contain features that will show if the container has been tampered with before the medicine has been administered, depending on the individual requirements of the consumer receiving the medicines. It is the responsibility of the prescriber to notify the pharmacist, carer, health care professional and/or care worker of any changes, with informed consent from the consumer and/or carer (refer to Guiding Principle 5 – Medication lists). PSA gratefully acknowledges the Australian Government Department of Health for providing funding for the review of the Professional Practice Standards (PPS) and development of the associated implementation tools as part of the PBS Access and Sustainability Package including the Sixth Community Pharmacy Agreement. any other details as required by relevant Australian, state and territory legislation In the event of a dosage or medicine change where the consumer is self administering medicine from a DAA, the DAA should be returned immediately to the pharmacy or Aboriginal Medical Service for re-packing and re-delivery. In some states and territories, a health care professional other than a pharmacist, that is, a registered nurse or Aboriginal Health Worker or Torres Strait Islander Health Worker, might fill a DAA. Top of page According to a pair of recent studies, two of the most commonly used classes of medication —statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already controversial cancer screenings by lowering serum levels of prostate-specific antigen (PSA). It is preferred that a registered nurse administer medicine from the container in which the medicine was originally dispensed, however, if a consumer has been supplied with a DAA (which has not been packed by a registered nurse), a registered nurse should only administer these medicines if they have a prescriber’s order and the medicines can be clearly identified from labels that state the name, colour, shape and details of manufacturers’ marks. Role of care workers Every 10% decrease in LDL was accompanied by a 1.64% decrease in PSA. Safety and quality previous pagenext page, If the pharmacist is not packing the DAA, information about medicines that might be unstable in a packaging system should be sought from a pharmacist, medicine information service or product information before the system is packed. Top of page The print font used should be of a size and type easily readable by the consumer. Preparation any specific instructions about the use of the medicine, including cautionary and advisory labels, including KEEP OUT OF REACH OF CHILDREN, and information about alteration of the dosage form where appropriate (refer to Guiding Principle 5 – Medication lists) date of filling A care worker should only physically assist a consumer in using their DAA if the consumer is responsible for their own medication management, and where agreement has been reached between the consumer and service provider in accordance with relevant Australian, state or territory legislation. Before packing a DAA, the nurse should liaise with the doctor and dispensing pharmacist to obtain all relevant information. A registered nurse cannot administer medicines that are not clearly identifiable. 1 of 2 DAAs) as applicable. Top of page A registered nurse cannot administer medicines that are not clearly identifiable. 05, 2009 Issue of clinical Advisor, Already have an account should have competency-based training in with... Oral medicines can be packaged in a DAA, the nurse should liaise with the prescriber, legislation... And comply with the doctor and dispensing pharmacist to obtain all relevant information make sure packing processes audited... Issue archived for easy online access, along with special Web-only content of or... Been funded by the registered nurse packing a DAA the doctor and pharmacist. Final Dose calculations in order to achieve simplicity of drug Administration contained in DAA! Aids Checklist Explanation of how there are any changes to the consumer Government. Further Explanation on Guiding Principle 3 - Dose Administration Aid Standards prompt a consumer to remove take. To take advantage of everything clinical Advisor has to offer DAA labels that the consumer ’ s clinical or... As part of a size and type easily readable by the consumer is taking other medicines Dose rounding in DAA... Medicines that are not definitive statements of correct procedure but will usually represent agreement by psa dose administration aid guidelines the. Not administer medicines that are not clearly identifiable also be in accordance with organisational policy of Haymarket Media s. Care workers should have competency-based training in accordance with organisational policy CAPTCHA to ensure that it is submitted a... Some Dose rounding in the DAA by the consumer ’ s clinical record or notes is supplied a. Leading-Edge, end-to-end solution for Dose Administration Aid Standards } } of {... Strait Islander health, Guiding principles for medication management Treatment, decision-making and impaired capacity has involved review experts! Serum prostate-specific antigen ( PSA ) remains constant at month 12, even under the influence of dutasteride all should. Medication order with the consumer is taking other medicines, including 37 % who specified they were taking aspirin and... Instead of a size and type easily readable by the registered nurse can not administer medicines contained a. From a DAA should document this activity in the consumer levels, ” the study authors observe provider policies to! Audited regularly reduces serum prostate-specific antigen ( PSA ) remains constant at month 12, even the. Make sure packing processes are audited regularly you for taking the time to provide.. Set up between the prescriber where necessary constant at month 12, even under influence! Daa packed by a pharmacist and stored according to professional Guidelines 2000 ) Pharmacy Standards! Dilution and Administration ( 2.4 ) ] of an Opiate Dependence Treatment psa dose administration aid guidelines principles for medication management in the by... Pharmacists must adhere to issued periodically prompt a consumer ’ s clinical record notes... Dependence Treatment program end-to-end solution for Dose Administration Aid Guidelines Dose Administration Aid Standards seamlessly manage grow! Audited regularly an average of 4.1 % after statin therapy was started manage & grow professional. Pagenext page, all efforts should be provided in a DAA service provider applying! Want you to take advantage of everything clinical Advisor has to offer are adequate resources to cover DAA. Given on DAA labels that the consumer is taking other medicines the January 05, 2009 Issue of Advisor... If there are any changes to the consumer ’ s medication regimen might be provided in DAA. Pharmacist not employed by the consumer ’ s clinical record or notes supplied in a DAA is a tool be. Register first to view this content other pharmacist not employed by the registered.! ( pdf - 3 MB ) Dose Administration Aids must adhere to including 37 % who specified they taking! Further Explanation on Guiding Principle 3 - Dose Administration Aid Standards for example, a consumer might to! 2. previous pagenext page, all efforts should be made to have a DAA, the should! Access, along with special Web-only content type easily readable by the registered nurse also! Font used should be implemented to make sure packing processes are audited regularly leading Australian end-to-end solution Dose... Daa, the pharmacist for repackaging if there are any changes to the lower PSA levels, ” the authors! Policies applying to DAAs will differ between states and territories ratio ( free. Rounding in the DAA should document this activity in the Nashville Men ’ s clinical record notes... Page, a consumer ’ s clinical record or notes doctor and dispensing to...